Combination of Ceftazidime-Avibactam and Meropenem for the Treatment of Pneumonia and Bloodstream Infections Caused by Pan-Drug Resistant Pseudomonas aeruginosa ST244: A Case Report

头孢他啶-阿维巴坦联合美罗培南治疗泛耐药铜绿假单胞菌ST244引起的肺炎和血流感染:病例报告

阅读:1

Abstract

CASE PRESENTATION: We describe a challenging case of a woman with Pseudomonas aeruginosa pneumonia and bloodstream infections following cardiothoracic surgery. This strain exhibited a pan-drug resistance phenotype belonging to the high-risk clone ST244. Finally, she was successfully treated by antibiotic therapy with ceftazidime/avibactam (CAZ/AVI) and meropenem (MEPM). CONCLUSION: This case suggests that the combination of CAZ/AVI and MEPM may represent a potential therapeutic option for severe infections caused by pan-drug-resistant Pseudomonas aeruginosa (PDR-PA).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。